COVETRUS, INC. Item 2.02 Results of Operations and Financial Condition.
On
The information in this Item 2.02 to this report is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 7.01 Regulation FD Disclosure.
On
The information in this Item 7.01, including Exhibit 99.1 to this report, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Forward-Looking Statements
This report, including Exhibit 99.1, contains certain statements that are
forward-looking within the meaning of Section 27A of the Securities Act, and
Section 21E of the Exchange Act. When used in this Report, the words
"anticipate," "assume," "believe," "budget," "continue," "could," "estimate,"
"expect," "intend," "may," "plan," "potential," "predict," "project," "should,"
"will," "future," and the negative of these or similar terms and phrases are
intended to identify forward-looking statements. Such statements are subject to
numerous risks and uncertainties, and actual results could differ materially
from those anticipated due to a number of factors including but not limited to:
the effect of health epidemics, including the COVID-19 pandemic, on our business
and the success of any measures we have taken or may take in the future in
response thereto, including vaccine mandates which may be required in certain
jurisdictions where we operate and increased turnover rates and absenteeism of
our labor force resulting from those mandates which may impact our ability to
continue operations at our distribution centers and pharmacies; the ability to
successfully integrate acquisitions, operations, and employees; the ability to
continue to execute on our strategic plan; the ability to attract and retain key
personnel; the ability to achieve performance targets, including managing our
growth effectively; the ability to manage relationships with our supplier and
distributor network, including negotiating acceptable pricing and other terms
with these partners; the ability to attract and retain customers in a price
sensitive environment; the ability to maintain quality standards in our
technology product offerings, as well as associated customer service
interactions to minimize loss of existing Customers, and attract new Customers;
access to financial markets along with changes in interest rates and foreign
currency exchange rates; changes in the legislative landscape in which we
operate, including potential corporate tax reform, and our ability to adapt to
those changes as well as adaptation by the third parties we are dependent upon
for supply and distribution; the impact of litigation; the impact of accounting
pronouncements, seasonality of our business, leases, expenses, interest expense,
and debt; sufficiency of cash and access to liquidity; cybersecurity risks,
including risk associated with our dependence on third-party service providers
as a large portion of our workforce is working from home; and those additional
risks and factors discussed under the heading "Risk Factors" in our Annual
Report on Form 10-K filed on
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
99.1 Investor Presentation
Cover Page Interactive Data File (embedded within the Inline XBRL
104 document)
--------------------------------------------------------------------------------
© Edgar Online, source
